Interesting Engineering on MSN
First-ever experimental gene therapy seeks to restore vision by rejuvenating eye neurons
Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...
A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...
Andrew G. Lee, MD, and Drew Carey, MD, discuss how optic disc cupping after optic neuritis reflects nerve and ganglion cell ...
A research team led by Professor Hyunji Lee of the Department of Convergence Medicine at Korea University College of Medicine (co-first authors: PhD candidates Sanghun Kim, Ji Eun Kim, and Sungjin Ju; ...
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
AZoLifeSciences on MSN
Postmortem human retinas recover neural light signals
The ability to restore light responses in human retinas postmortem offers a novel model for studying retinal recovery and ...
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...
The IPL's microstructure may serve as a biomarker for early diagnosis of diseases affecting synaptic health, including ...
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, ...
Opioids are widely used to relieve the pain associated with oral squamous cell carcinoma (OSCC), but tolerance and undesired effects often limit their use. EGFR is commonly amplified in oral cancer ...
Life Biosciences plans to begin human clinical trials of a cellular rejuvenation therapy in optic neuropathies after ...
In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results